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Abstract
Introduction: The main objective of this study was to determine whether meniscus cells from the outer (MCO)
and inner (MCI) regions of the meniscus interact similarly to or differently with mesenchymal stromal stem cells
(MSCs). Previous study had shown that co-culture of meniscus cells with bone marrow-derived MSCs result in
enhanced matrix formation relative to mono-cultures of meniscus cells and MSCs. However, the study did not
examine if cells from the different regions of the meniscus interacted similarly to or differently with MSCs.
Methods: Human menisci were harvested from four patients undergoing total knee replacements. Tissue from the
outer and inner regions represented pieces taken from one third and two thirds of the radial distance of the
meniscus, respectively. Meniscus cells were released from the menisci after collagenase treatment. Bone marrow
MSCs were obtained from the iliac crest of two patients after plastic adherence and in vitro culture until passage 2.
Primary meniscus cells from the outer (MCO) or inner (MCI) regions of the meniscus were co-cultured with MSCs in
three-dimensional (3D) pellet cultures at 1:3 ratio, respectively, for 3 weeks in the presence of serum-free
chondrogenic medium containing TGF-b1. Mono-cultures of MCO, MCI and MSCs served as experimental control
groups. The tissue formed after 3 weeks was assessed biochemically, histochemically and by quantitative RT-PCR.
Results: Co-culture of inner (MCI) or outer (MCO) meniscus cells with MSCs resulted in neo-tissue with increased
(up to 2.2-fold) proteoglycan (GAG) matrix content relative to tissues formed from mono-cultures of MSCs, MCI and
MCO. Co-cultures of MCI or MCO with MSCs produced the same amount of matrix in the tissue formed. However,
the expression level of aggrecan was highest in mono-cultures of MSCs but similar in the other four groups. The
DNA content of the tissues from co-cultured cells was not statistically different from tissues formed from mono-
cultures of MSCs, MCI and MCO. The expression of collagen I (COL1A2) mRNA increased in co-cultured cells relative
to mono-cultures of MCO and MCI but not compared to MSC mono-cultures. Collagen II (COL2A1) mRNA
expression increased significantly in co-cultures of both MCO and MCI with MSCs compared to their own controls
(mono-cultures of MCO and MCI respectively) but only the co-cultures of MCO:MSCs were significantly increased
compared to MSC control mono-cultures. Increased collagen II protein expression was visible by collagen II
immuno-histochemistry. The mRNA expression level of Sox9 was similar in all pellet cultures. The expression of
collagen × (COL10A1) mRNA was 2-fold higher in co-cultures of MCI:MSCs relative to co-cultures of MCO:MSCs.
Additionally, other hypertrophic genes, MMP-13 and Indian Hedgehog (IHh), were highly expressed by 4-fold and
18-fold, respectively, in co-cultures of MCI:MSCs relative to co-cultures of MCO:MSCs.
Conclusions: Co-culture of primary MCI or MCO with MSCs resulted in enhanced matrix formation. MCI and MCO
increased matrix formation similarly after co-culture with MSCs. However, MCO was more potent than MCI in
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suppressing hypertrophic differentiation of MSCs. These findings suggest that meniscus cells from the outer-
vascular regions of the meniscus can be supplemented with MSCs in order to engineer functional grafts to
reconstruct inner-avascular meniscus.
Introduction
The meniscus of the knee joint serves a variety of criti-
cal functions that include shock absorption, cartilage
protection, and joint stability [1-3]. The capacity to per-
form these functions is by virtue of its extracellular
matrix (ECM) composition and assembly, which is
accomplished entirely by meniscus fibrochondrocytes
[4,5]. The ECM consists predominantly of type I col-
lagen throughout, type II collagen in the inner meniscus,
and proteoglycans, of which aggrecan is predominant
[6-8]. Unfortunately, the reparative capacity of the
meniscus is hindered by limited vascularization [9]. In
human meniscus, the capillary plexus supplies only the
outer one third [10] whereas the inner two thirds are
avascular; if left untreated, defects in this portion do not
heal and may lead to further joint degeneration [11,12].
Current treatment options include partial and total
meniscectomies, depending on the extent of meniscal
injury [13]. However, these procedures are major risk
factors for the early development of osteoarthritis (OA)
[13-16]. Cell-based regenerative medicine and tissue
engineering have been advocated options to produce
functional substitutes to aid repair or replace damaged
tissue [17-28]. However, current protocols suffer from
several drawbacks that include insufficient numbers of
differentiated meniscus cells and loss of ECM-forming
phenotype of in vitro-propagated meniscus cells. There-
fore, alternative cell sources or cell-based strategies are
of interest in meniscus tissue engineering.
Adult-derived mesenchymal stromal stem cells (MSCs)
are of particular interest in meniscus tissue engineering
because of their capacity to undergo differentiation into
a variety of mesenchymal lineages, including cartilage
and bone [17,29,30]. Additionally, MSCs secrete soluble
trophic factors that are capable of promoting cell prolif-
eration and differentiation and suppressing local
immune system through both autocrine and paracrine
mechanisms [31-35]. However, specific factors known to
induce MSCs toward the meniscus cell phenotype are
unknown. Co-culture of MSCs with primary meniscus
cells is a stratagem that both provides inductive factors
and mitigates the need for meniscus cell expansion and
associated dedifferentiation of meniscus cells during in
vitro culture expansion [32,34-38]. Recent work in our
laboratory demonstrated that supplementation of human
primary meniscus cells with human bone marrow MSCs
results in increased meniscus matrix-forming phenotype
[39]. Similar work by Cui and colleagues [40]
additionally demonstrated that co-cultures of primary
human meniscus cells with bone marrow MSCs result
in suppression of hypertrophic differentiation of bone
marrow MSCs. However, both studies used meniscus
cells taken from the whole meniscus and it is not clear
whether the cells from the outer and inner menisci will
interact similarly or distinctly with bone marrow MSCs.
Previous studies have shown that the meniscus cells
from the outer and inner regions of the meniscus have
distinct ECM gene profiles as well as different multi-
lineage differentiation characteristics [41-43]. Moreover,
inner meniscus cells display a more chondrogenic phe-
notype relative to outer meniscus cells on the basis of
inherently higher collagen II and aggrecan content
[42,43]. Furthermore, outer meniscus cells displayed a
more chondrogenic response to hypoxic stimuli by
enhanced expression of chondrogenic genes, collagen II
and Sry-related HMG box 9 (sox9), than cells isolated
from the inner and avascular regions of the meniscus
[44]. In this study, we explored the concepts that (a)
cells of outer and inner menisci have the capacity to
enhance matrix formation of meniscus cells after co-cul-
ture with MSCs and (b) cells from the outer and self-
healing regions of the meniscus may serve as a clinical
source of cells in co-culture tissue engineering strategies
with MSCs to recapitulate the functional matrix-forming
phenotype of the inner meniscus, which has a limited
reparative capacity.
Materials and methods
Collection of bone marrow specimens and culture of
bone marrow stem cells
Bone marrow aspirates were obtained from surgically
discarded material after approval and a waiver of
informed consent of the local ethical committee of the
University of Alberta (Edmonton, AB, Canada) during
routine orthopedic procedures from the iliac crest of
two female donors (ages of 23 and 59 years). The num-
ber of nucleated cells in the aspirates was determined by
crystal violet nuclei staining and counting on a hemo-
cytometer. Thereafter, 15 million nucleated cells per
150-cm2 tissue culture flask were seeded. Culture med-
ium was alpha minimum essential medium supplemen-
ted with 10% heat-inactivated fetal bovine serum, 1 mM
sodium pyruvate, 100 mM HEPES buffer, 1 mM sodium
pyruvate, 100 U/mL penicillin, 100 μg/mL streptomycin,
and 0.29 mg/mL L-glutamine (all from Invitrogen, Mis-
sissauga, ON, Canada) and 5 ng/mL of basic fibroblast
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growth factor 2 (FGF-2) (Humanzyme-Medicorp Inc.,
Montreal, QC, Canada). Nucleated cells were allowed to
adhere and grow for 7 days before the first media
change under normal oxygen tension (21% O2 and 95%
air) at 37°C in a humidified incubator with 5% CO2.
Thereafter, media change was implemented twice per
week until 70% to 80% cell confluence was attained.
These adherent bone marrow MSCs were detached by
using trypsin-ethylenediaminetetraacetic acid (trypsin-
EDTA) (0.05% wt/vol) and expanded until passage 2
prior to experimental use. We included FGF-2 through-
out MSC cultivation as it maintains human MSCs in an
immature state for in vitro expansion [45].
Isolation of human meniscus cells
Menisci were obtained from surgically discarded mate-
rial after approval and a waiver of informed consent of
the local ethical committee of the University of Alberta.
Both lateral and medial menisci were harvested from
the knee joint of four female donors (age of 55 to 71
years and mean age of 62 ± 6.8 years) undergoing total
knee arthroplasty. Tissue from the outer and inner
regions represented pieces taken from one third and
two thirds of the radial distance, respectively. Meniscus
cells were released via treatment with type II collagenase
(0.2% wt/vol; Worthington, Lakewood, NJ, USA) after
16-hour digestion of tissue at 37°C in a standard med-
ium-high glucose Dulbecco’s modified Eagle’s medium
containing 4.5 mg/mL D-Glucose (DMEM-HG), 0.1
mM non-essential amino acids, 1 mM sodium pyruvate,
100 mM HEPES buffer, 1 mM sodium pyruvate, 100 U/
mL penicillin, 100 μg/mL streptomycin, and 0.29 mg/
mL L-glutamine (all from Invitrogen) supplemented
with 10% fetal bovine serum (Invitrogen). Meniscus cells
from the outer meniscus region were labeled as MCO,
and those from the inner portion of the meniscus were
designated as MCI. The cell suspension obtained after
digestion was passed through a 70-μm nylon-mesh filter.
Isolated cells were plated at 104 cells/cm2 and cultured
in standard medium for 24 hours under normal oxygen
tension (21% O2 and 95% air) at 37°C in a humidified
incubator with 5% CO2 before experimental use. Non-
adherent cells were aspirated off while adherent cells
were detached with trypsin-EDTA (0.05% wt/vol)
(Invitrogen).
Chondrogenic differentiation
Mono-culture in pellets of MSCs, MCO, and MCI were
formed in 250 μL of serum-free chondrogenic culture
medium consisting of standard medium supplemented
with 0.1 mM ascorbic acid 2-phosphate, 10−5 M dexa-
methasone, 1x ITS+1 premix (Sigma-Aldrich, Oakville,
ON, Canada), and 10 ng/mL transforming growth
factor-beta 1 (TGF-b1) (Humanzyme-Medicorp Inc.) as
described previously [35]. A total of 2.5 × 105 cells were
spun in 1.5 mL of sterile conical polypropylene micro-
fuge tubes (Enzymax LLC, Lexington, KY, USA) at 1,500
revolutions per minute for 3 minutes to form spherical
cell pellets. Co-cultures in pellet form consisting of
MCO/MSCs or MCI/MSCs were formulated by mixing
the two cell types at a 1:3 ratio, respectively. Preliminary
studies with a variety of ratios had shown a ratio of 1:3
to reproducibly result in enhanced matrix formation,
but identification of the optimal cell-cell ratio remains
to be determined [46]. After 3 weeks of culture with
media changes three times per week, pellets were pro-
cessed biochemically for glycosaminoglycan (GAG) and
DNA contents, histologically, and immuno-histochemi-
cally and by quantitative reverse transcription-polymer-
ase chain reaction for gene expression analysis. For each
experiment (four in total), there were two experimental
groups (co-culture of MCO/MSCs and co-culture of
MCI/MSCs) and three control groups (mono-culture of
MSCs, mono-culture of MCO, and mono-culture of
MCI). At least two or three replicate pellets per control
or experimental group were assessed for each
experiment.
Biochemical analysis
All in vitro cultivated pellets were rinsed in phosphate-
buffered saline (Invitrogen) and digested in proteinase K
(1 mg/mL in 50 mM Tris with 1 mM EDTA, 1 mM
iodoacetamide, and 10 mg/mL pepstatin A; all from
Sigma-Aldrich) for 16 hours at 56°C. The sulphated
GAG content was measured by 1,9 dimethylmethylene
blue binding (Sigma-Aldrich) by using chondroitin sul-
phate (Sigma-Aldrich) as standard [47]. The DNA con-
tent was determined by using the CyQuant cell
proliferation assay kit (Invitrogen) with supplied bacter-
iophage l DNA as standard. Based on experimental
GAG values of mono-culture of MSC, MCO, or MCI
pellets, the expected GAG values were calculated as a
linear function of the proportion (percentage) of MSCs
and MCO or MSCs and MCI by using the following
equations [35,39]:
GAGexpected = [(GAG100% MSCs ×%MSCs) + (GAG100% MCI ×%MCI)]
GAGexpected = [(GAG100% MSCs ×%MSCs) + (GAG100% MCO ×%MCO)].
The interaction index or measure of chondro-induc-
tion was then calculated as the ratio of measured GAG
(that is, GAGmeasured) in co-cultured pellets to expected
GAG (that is, GAGexpected). If the value of the ratio is
greater than 1, then chondro-induction, an enhanced
chondrogenic matrix formation, is considered to have
taken place [35,39].
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Histology and immuno-histochemistry
Tissues generated from the pellet cultures were fixed in
4% phosphate-buffered formalin, processed into paraffin
wax, sectioned at 5 μm, and stained with 1% Alcian blue
and counterstained with 1% neutral red stain to reveal
sulphated proteoglycan (GAG) matrix depositions.
Other sections were probed with antibodies raised
against collagen types I and II. Sections were digested
with trypsin and then incubated with antibodies against
collagen I (MAB3391) from Millipore (Temecula, CA,
USA) or collagen II (II-II6B3) from the Developmental
Studies Hybridoma Bank at the University of Iowa (Iowa
City, IA, USA). Immuno-localized antigens were visua-
lized with goat anti-mouse IgG biotinylated secondary
antibody (Dako Canada Inc., Mississauga, ON, Canada)
and a streptavidin-horseradish peroxidase labeling kit
with 3,3’-diaminobenzidine (Dako Canada Inc.). Images
were captured by using an Omano OM159T biological
trinocular microscope (Microscope Store, Roanoke, VA,
USA) fitted with an Optixcam summit series 5MP digi-
tal camera and Optixcam software and assembled in
Adobe Photoshop (Adobe Systems Inc., Mountain View,
CA, USA).
Gene expression analysis
Total RNA was extracted from pellets by using Tri-
Reagent (Sigma-Aldrich) after grinding with Molecular
Grinding Resin (Geno Technology Inc., St. Louis, MO,
USA) in combination with the use of an Aurum Total
RNA Fatty and Fibrous Tissue Kit (Bio-Rad, Missis-
sauga, ON, Canada) and after removal of contaminating
genomic DNA from the pellets by DNase treatment. To
minimize changes in gene expression during cell pellet
harvest, cell pellets were immediately (less than 1 min-
ute) transferred into Tri-Reagent. Total RNA (100 ng)
in a 40-μL reaction was reverse-transcribed to cDNA by
using GoScript reverse transcriptase primed with oligo
(dT)15 primer (Fisher Scientific, Whitby, ON, Canada).
Quantitative real-time polymerase chain reaction was
performed in DNA Engine Opticon II Continuous
Fluorescence Detection System (Bio-Rad) by using hot
start Taq and SYBR Green detection (Eurogentec North
America Inc., San Diego, CA, USA). Primer sequences
for collagen I (COL1A2), collagen II (COL2A1), collagen
× (COL10A1), aggrecan, versican, SOX9, and b-actin
(Table 1) were taken from previously published work or
were custom designed by using Primer Express software
(Applied Biosystems, Foster City, CA, USA) [44,48,49].
All primers were obtained from Invitrogen. Gene
(mRNA) expression levels for each primer set were nor-
malized to the expression level of b-actin by the 2-Δct
method [50].
Statistical analysis
Data are presented as mean ± standard error of mean of
measurements. All statistical analyses were performed
by using SPSS version 18 (PASW Statistics 18; SPSS
Inc., Chicago, IL, USA) unless stated otherwise. Experi-
mental and control groups were compared with one-
way analysis of variance with Tukey’s multiple compari-
son post hoc tests. Statistical differences between chon-
dro-induction indices of MCO and MSC experimental
groups and/or MCI and MSC experimental groups were
assessed by paired two-tailed Student t test distribution.
All statistical differences were considered to be signifi-
cant with a P value of less than 0.05.
Table 1 Primer sequences used in quantitative real-time polymerase chain reaction


















































All primers were purchased from Invitrogen (Mississauga, ON, Canada). COL1A2, type II collagen a2 chain; COL2A1, type I collagen a1 chain; COL10A1, type ×
collagen a1 chain; IHh, Indian Hedgehog; MMP-13, matrix metalloproteinase 13; SOX9, Sry-related HMG box 9.
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Results
Enhanced synthesis of glycosaminoglycan matrix in co-
cultured pellets of meniscus cells and mesenchymal
stromal cells
To characterize the ECM accumulated after pellet cul-
ture, the amount of GAG matrix production per cellular
DNA content was quantified (Figure 1A). All pellets
from co-cultured cells displayed a significantly higher (P
<0.01) GAG per DNA content (a measure of chondro-
genic capacity) than pellets derived from mono-cultures
of MSCs. However, the GAG per DNA content of co-
cultured pellets was not significantly (P >0.05) different
from that of pellets formulated from mono-cultures of
MCI or MCO (Figure 1A), thus indicating that the
enhanced capacities to synthesize the cartilaginous-type
ECM of the MCO or MCI in co-culture with MSCs are
similar.
To determine whether changes in the number of cells
accounted for the difference or similarities in chondro-
genic capacities of the co-cultured pellets relative to pel-
lets from mono-cultures of MSCs, MCO, and MCI, we
determined the DNA content since DNA content per
cell is 11.6 pg [51]. All pellets were not significantly (P
>0.05) in DNA content (Figure 1B).
To quantify the different enhanced capacity of the co-
cultured pellets and MSCs to produce GAG-type matrix,
the chondrogenic index was calculated as the ratio of
the experimental GAG value to the expected GAG
value. Expected GAG value was determined as a linear
function of the proportion of meniscus cells (that is,
MCI or MCO) and MSCs in co-cultured pellets (Equa-
tions 1 and 2). Chondrogenic indices that exceeded 1
were considered to display chondro-induction, which is
an enhancement in chondrogenic capacity. All co-cul-
tured pellets had chondro-induction indices of above 1.
Chondro-induction indices ranged from 1.2 to 2.1 for
MCI/MSC co-cultures and from 1.4 to 2.2 for MCO/
MSC co-cultures (Figure 1C). However, there was no
significant difference between the two groups.
Histological assessment of matrix deposition in co-culture
of meniscus cells and mesenchymal stromal stem cells
Cells were cultured from four donor pairs; primary
meniscus cells from the outer (MCO) or inner (MCI)
region of the meniscus with bone marrow MSCs were
cultured, in separate pellets (mono-cultured pellets) or
after being mixed (co-cultured pellets), for 3 weeks in
serum-free medium supplemented with chondrogenic
factors (TGF-b1, ascorbic acid, and dexamethasone).
Representative data from co-cultured pairs of four
donors are shown in Figure 2. All five groups were posi-
tive for proteoglycan staining by safranin O (Figure 1, 2)
and Alcian blue (Figure 1, 2) after chondrogenic
stimulation (Figure 2). Relative to the mono-cultured
pellets (Figure 2B1, B3, and 2B5), the Alcian blue stain-
ing intensity in co-cultured pellets (Figure 2B2 and 2B4)
appeared to be more intense and homogenously
distributed.
Immuno-histochemical assessment of all mono-cul-
tured and co-cultured pellets was performed by using
antibodies to types I and II collagen. All pellets stained
positively (brown coloration) for types I and II collagen.
Representative photomicrographs for collagen I are
shown in Figures 1, 2 and for collagen II in Figures 1, 2.
Collagen I stain was evenly distributed in all cell pellets
(Figures 1, 2). In contrast, with the exception of mono-
culture pellets of MSCs (Figure 2D1), collagen II stain-
ing was not homogenously distributed over entire pellets
(Figure 2). Mono-cultured pellets of MCI (Figure 2D3)
were labeled predominantly with collagen II in the cen-
tral portion of the pellets, whereas pellets from MCO
(Figure 2D5) were labeled positively with collagen II in
one area of the pellets. Co-cultured pellets of MCI (Fig-
ure 2D2) or MCO (Figure 2D4) with MSCs displayed a
more intense brown coloration for collagen II than any
of the mono-cultured pellets especially prominent at the
peripheral rim of the co-cultured pellets. Representative
primary antibody control pellets consisting of a 1:3
MCO/MSCs ratio were negative and showed no false
background staining (Figure 2E).
Gene expression profile in mono-cultures and co-cultures
of meniscus cells and mesenchymal stromal stem cells
The relative mean expressions of aggrecan, collagen I
(COL1A2), collagen II (COL2A1), collagen ×
(COL10A1), matrix metalloproteinase 13 (MMP-13),
Indian Hedgehog (IHh), SOX9, and versican were evalu-
ated at the mRNA level in pellets derived from mono-
cultures of MCI, MCO, and MSCs and from co-cultures
of MCI or MCO with MSCs (Figure 3). Mono-cultures
of MSCs significantly (P <0.05) expressed the highest
(twofold) level of aggrecan mRNA relative to all other
pellet cultures (Figure 3A). There was no statistical dif-
ference between aggrecan expression in mono-cultures
of MCI or MCO and co-cultures of MCI or MCO with
MSCs (Figure 3A).
There was no statistically significant difference
between the relative mean expression of COL1A2 in co-
cultures of MCO or MCI with MSCs (Figure 3B). The
expression of COL1A2 was significantly higher (approxi-
mately 10-fold, P <0.0001) in mono-cultures of MSCs
and in co-cultures of MCI/MSCs compared with mono-
cultures of MCI but was not different between mono-
cultures of MSCs and co-cultures of MCI/MSCs (Figure
3B). In contrast, there was no statistical difference
between the relative mean expression of COL1A2 in
Saliken et al. Arthritis Research & Therapy 2012, 14:R153
http://arthritis-research.com/content/14/3/R153































































































Figure 1 Chondrogenic capacities of outer or inner meniscus cells in co-culture with mesenchymal stromal cells (MSCs) are similar.
Biochemical analysis was used to evaluate the chondrogenic differentiation capacities (GAG/DNA) and the chondrogenic differentiation indices of the
pellets from MSCs, MCI/MSCs, MCI, MCO/MSCs, and MCO after 3 weeks of culture in chondrogenic medium (transforming growth factor-beta 1,
dexamethasone, and ascorbate). Chondrogenic induction index was calculated with equations 1 and 2 in the Biochemical analysis subsection of
Materials and methods. If the chondro-induction index was greater than 1, an enhancement in chondrogenic matrix formation was considered to
have occurred. Data are presented as mean ± standard error of mean of four donor pairs. One-way analysis of variance with Tukey’s multiple
comparison post tests: *significance when compared with mono-cultures of meniscus cells - outer meniscus cells (MCO) or inner meniscus cells (MCI) -
and MSC pellet controls (P <0.05); **significance when compared with MCO or MCI and MSC pellet controls (P <0.0001). Paired two-tailed Student t
statistics: no significance (n.s.) (P >0.05) between chondro-induction indices of co-cultures of MCO or MCI and MSCs. GAG, glycosaminoglycan; MCI,
meniscus cells from inner meniscus region; MCO, meniscus cells from the outer meniscus region.
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mono-cultures of MCO and co-cultures of MCO/MSCs
(Figure 3B).
The mean expression of COL2A1 mRNA was twofold
higher in co-cultured pellets of MCO/MSCs relative to
mono-cultures of MSCs/MCO (Figure 3C). The expres-
sion of COL2A1 in co-cultures of MCI/MSCs was not
significantly different (P >0.05) from its expression in
mono-cultures of MSCs. However, COL2A1 expression
in co-cultures of MCI/MSCs was ninefold (P <0.001)
greater than its expression in mono-cultures of MCI
(Figure 3C).
The gene expressions of hypertrophic genes,
COL10A1, MMP-13, and IHh, were determined (Figure
3D-F). The relative mean expression level of COL10A1
was significantly different (P <0.001) and highest in
mono-cultured pellets of MSCs relative to other mono-
cultured and co-cultured pellets (Figure 3D), and its
expression was least in mono-cultures of MCI or MCO.
The addition of MCI or MCO to MSCs in co-cultured
pellets resulted in a highly significant suppression of
COL10A1 mRNA when compared with its expression in
mono-cultures of MSCs (Figure 3D). MCO significantly
(P <0.05) suppressed the mRNA expression of COL10A1
by twofold more than its MCI counterpart (Figure 3D).
The relative mean expression level of MMP-13 was not
statistically different between mono-cultures of MSCs
and MCI, nor was there any statistical difference
between mono-culture MSCs and co-cultures of MSCs
Figure 2 Histological and immunohistochemical analysis of mono-cultured and co-cultured cell pellets after 21 days of culture. The
expression of matrix proteoglycans (glycosaminoglycanated proteins) in pellet cultures was detected by Safranin O (series A) and Alcian blue/
neutral red stain (series B). Extracellular matrix deposition of collagen types I (series C) and II (series D) was detected by immuno-histochemistry
(IHC) in mono-cultured (MCI, MCO, and MSC) and co-cultured (MCI/MSCs or MCO/MSCs) cell pellets after 3 weeks of culture in chondrogenic
medium (transforming growth factor-beta 1, dexamethasone, and ascorbate). Representative primary antibody control pellets of a 1:3 MCO/MSCs
ratio is shown in E. All photomicrographs were captured via a 10× magnification lens. Scale bar is 100 μm. Ab, antibody; MCI, meniscus cells
from inner meniscus region; MCO, meniscus cells from the outer meniscus region; MSC, mesenchymal stromal cells.
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Figure 3 Gene expression analysis of mono-cultured and co-cultured cell pellets after 21 days of culture. Quantitative mRNA gene expression
analysis via SYBR Green detection was used to evaluate the expression of a panel of fibrogenic (Collagen I and Versican) and chondrogenic (Aggrecan,
Collagen II and SOX9) marker genes as well as the expression of genes characteristic of hypertrophic differentiation of MSCs (Collagen X, MMP-13 and
Indian Hedgehog) in pellets from MSCs, MCI/MSCs, MCI, MCO/MSCs, and MCO after 3 weeks of culture in chondrogenic medium (transforming
growth factor-beta 1, dexamethasone, and ascorbate). Each data point represents the mean ± standard error of the mean of four donor pairs. One-
way analysis of variance with Tukey’s multiple comparison post tests: *significance when compared with mono-cultures of meniscus cells - outer
meniscus cells (MCO) or inner meniscus cells (MCI) - and MSC pellet controls (P <0.05) or when compared with mono-cultures of MCO versus mono-
cultures of MCI; **significance when compared with co-cultures of MCO or MCI and MSC pellet controls (P <0.01); ***significance when compared
with MCO or MCI and MSC pellet controls (P <0.0001). No significance (n.s.) (P >0.05). All marker gene expression was presented as relative mRNA level
normalized to human b-actin (y-axis); (A) Aggrecan, (B) Collagen I (COL1A2), (C) Collagen II (COL2A1), (D) Collagen × (COL10A1), (E) MMP-13, (F) Indian
Hedgehog (IHh), (G) Sox9, and (H) Versican MCI, meniscus cells from inner meniscus region; MCO, meniscus cells from the outer meniscus region;
MMP-13, matrix metalloproteinase 13; MSC, mesenchymal stromal cell; SOX9, Sry-related HMG box 9.
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and MCI (Figure 3E). However, the mean relative
expression of MMP-13 in mono-cultures of MSCs was
threefold higher than its expression in co-cultures of
MSCs and MCO. The expression of MMP-13 was four-
fold higher in MSC/MCI co-cultures relative to expres-
sion in MCO/MSC co-cultures (Figure 3E). The
expression of IHh was highest in mono-cultures of
MSCs and lowest in co-cultures of MCO and MSCs
(Figure 3F). The expression of IHh in mono-cultures of
MSCs was 2.3-fold higher (P <0.05) than in co-cultures
of MSCs and MCI. However, when IHh gene expression
in MSC mono-cultures was compared with its expres-
sion in MCO/MSC co-cultures, it was 44-fold higher (P
<0.0001). Additional comparison showed that the
expression of IHh in MCI/MSCs relative to expression
in MCO/MSCs was 18-fold higher (P <0.001) (Figure
3F).
The expression of Sox9, a transcription factor known
to facilitate COL2A1 expression, was not significantly
different between most pellet cultures except in mono-
cultures of MCO, where its relative mean expression
level was almost twofold lower compared with the other
pellets (Figure 3G). There was no statistically significant
difference between mono-cultured and co-cultured pel-
lets with regard to mRNA expression of versican (Figure
3H).
Discussion
Our previous study demonstrated that direct cell-to-cell
co-culture of primary human meniscus cells from all
regions of the meniscus with bone marrow-derived
MSCs resulted in increased matrix formation [39]. How-
ever, we did not determine if the cells from the outer-
vascular and inner-avascular regions of the meniscus
interacted with MSCs similarly or otherwise. The
response of cells of outer and inner menisci to culture
conditions and growth factors is different, and the
expression of COL2A1 and aggrecan is higher in mono-
layer cultures of porcine inner meniscus cells than in
outer meniscus cells [42]. We showed that, in aggregate
cultures of human inner and outer meniscus cells in the
presence of TGF-b1, hypoxia (5%) increased the expres-
sion of Sox9 in outer meniscus cells but not in inner
meniscus cells [44].
In this study, we isolated cells from the inner and
outer regions of the meniscus and co-cultured the cells
separately with bone marrow-derived MSCs by using
the scaffold-free three-dimensional pellet model of tissue
formation. Co-culture of primary inner or outer menis-
cus cells with MSCs resulted in enhanced matrix forma-
tion since the calculated interaction indices were greater
than 1. This finding was consistent with the data from
our recent work on co-culture of whole meniscus cells
with MSCs [35]. Furthermore, our results corroborated
the findings of similar studies that involved co-culture
of chondrocytes or intervertebral discs with MSCs and
that resulted in enhanced matrix synthesis [32,35]. The
mechanism underlying the enhancement of matrix
synthesis was not explored in this study. However, it
was interesting to find that the cellularities of the pellets
(as judged by the DNA content of our pellets) were not
statistically different among experimental and control
groups. In a previous study involving co-culture of pri-
mary chondrocytes and MSCs, enhanced matrix synth-
esis was attributed to a synergistic increase in
chondrocyte proliferation and induced chondrogenesis
of MSCs [35]. However, the lack of difference between
the DNA contents of the pellets in this study suggests
that the underlying mechanism is most likely indepen-
dent of changes in cell proliferation. Moreover, our
DNA data are consistent with the findings of Furumatsu
and colleagues [43], who showed that the proliferation
rates of both inner and outer human meniscus cells
were the same in the presence of TGF-b1 (10 ng/mL) as
used in this study. Other mechanistic possibilities may
involve a synergistic cross-talk mediated by soluble fac-
tors from both meniscus cells and MSCs [31,52].
Histological and biochemical analyses of the pellets in
this study revealed that the cells from the outer and
inner regions of the meniscus interacted almost indistin-
guishably with MSCs. Proteoglycan staining via safranin
O and Alcian blue stains were similar, and the GAG
content normalized to DNA content were also similar
(Figure 1). This finding was surprising as Furumatsu
and colleagues [43] recently reported that human inner
meniscus cells have a higher GAG content than outer
meniscus cells, even after cultivation in chondrogenic
factors. The reason for this is not clear but may be asso-
ciated with differences in the severity of OA in the spe-
cimens used in this study. Furumatsu and colleagues
used specimens from medial-affected OA joints (that is,
specimens from joints with sufficient articular cartilage
of lateral femoral condyle and undegenerated lateral
meniscus), whereas this study used both lateral and
medial menisci from joints with macroscopically diverse,
degenerated articular cartilage of lateral and medial
femoral condyles. This possibility is further supported
by the findings of Sun and colleagues [53], who demon-
strated that altered gene expression profiles exist
between OA and normal menisci.
Collagen I (COL1A2) is the predominant collagen type
and ECM molecule in meniscus [5,6]. Co-culture of
inner or outer meniscus cells with MSCs resulted in the
upregulation of COL1A2 transcription, as we previously
reported [39]. Similarly to previous findings, at the pro-
tein level, collagen I deposition was qualitatively the
same in all pellets. Furthermore, there was no statistical
difference between its transcriptional expressions in the
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two co-cultures. Similarly to our previous findings with
co-cultures of whole meniscus cells and MSCs [39], the
levels of expression of COL1A2 in co-cultures of inner
or outer meniscus cells with MSCs appear to be orche-
strated by the MSC component since the level of
COL1A2 expression in mono-cultures of MSCs was not
surpassed. The underlying mechanism for this regula-
tory role of MSCs is not clear at this point but may be
related to trophic activities of MSCs [31,54]. Nonethe-
less, our data were consistent with our previous findings
that COL1A2 expression is higher in human outer
meniscus cells than in inner meniscus cells chondro-
genic culture [44].
We investigated the gene expression of aggrecan,
which is the predominant proteoglycan of the meniscus
[55], and versican, another proteoglycan expressed in
the meniscus [56], to confirm our histological and bio-
chemical findings. The relative expression levels of
aggrecan and versican were not statistically different
between co-cultures of inner or outer meniscus cells
with MSCs, nor was there any difference between their
expression in mono-cultures of inner and outer human
meniscus cells (Figure 3A). These findings seem con-
trary to previous reports that the mRNA expression of
aggrecan is higher in inner meniscus cells than in outer
meniscus cells. Further contrasts to previous findings
were noted in our results on collagen II (COL2A1)
expression. Our data demonstrated that the expression
of COL2A1 was least in mono-cultures of inner menis-
cus cells and highest in co-cultures of outer or inner
meniscus cells with MSCs relative to mono-cultures of
MSCs or outer meniscus cells. However, previous find-
ings by us [44] and Furumatsu and colleagues [43]
demonstrated that COL2A1 and Sox9 (a transcription
factor known to promote COL2A1) expression in inner
meniscus cells was higher relative to their expression in
outer meniscus cells, even in the presence of chondro-
genic factors. A plausible reason for this disparity
between our findings here and those of previous studies
is donor-donor variability (age, gender, and so on) or, as
alluded to earlier, the association with possible differ-
ences in the severity of OA among study specimens
[53,57]. Additionally, it is probable that differences in
the multi-potential characteristics of outer and inner
meniscus cells play a contributing factor. Mauck and
colleagues [41] showed that bovine meniscus cells from
the inner and outer regions of the meniscus exhibit dif-
ferent multi-lineage differentiation capabilities. Cells
from the outer region were more plastic than inner
meniscus cells, differentiating along all three mesenchy-
mal lineages (adipogenesis, chondrogenesis, and osteo-
genesis). Mauck and colleagues also showed that, when
outer or inner meniscus cells were treated with chon-
drogenic factors (as in this study), inner and outer cell
populations expressed similar levels of aggrecan. In con-
trast, in the absence of chondrogenic factors, the expres-
sion of aggrecan in inner meniscus is significantly higher
than its expression in outer meniscus [42]. Despite the
dissimilarities in our aggrecan and COL2A1 data relative
to previous reports, it was interesting that the expres-
sion of Sox9 and COL2A1 correlated linearly in mono-
cultures of MSCs and MCO and in co-cultures of
MCO/MSCs but inversely in mono-cultures of MCI
(Figure 3C,E). The expressions of Sox9 and COL2A1
often are not correlated [57-59], but our findings sug-
gest that, although Sox9 is necessary for COL2A1
expression, other factors may facilitate COL2A1 tran-
scription in inner meniscus. These factors may be parti-
cularly active in specimens derived from OA joints and
perhaps reflect the similarities of the inner meniscus
and articular cartilage [30,53,57]. The deposition and
distribution of collagen II were notably enhanced in co-
cultures of inner or outer meniscus cells with MSCs and
in mono-cultures of MSCs. This correlated with our
previous findings involving whole meniscus cells and
MSCs [39].
Further gene expression analysis showed statistically
significant differences between the expressions of hyper-
trophic genes, COL10A1, IHh, and MMP-13, in co-cul-
tures of MSCs with outer or inner meniscus cells.
COL10A1, IHh, and MMP-13 are predominantly
expressed by hypertrophic chondrocytes during endo-
chondral ossification [60]. COL10A1 is also a hyper-
trophic marker for OA cartilage and OA meniscus
[61,62]. Expression of both IHh and MMP-13 modulates
hypertrophic differentiation of chondrocytes during
endochondral ossification. IHh is produced by hyper-
trophic chondrocytes and, in turn, stimulates secretion
of parathyroid hormone-related protein (PTHrP), which
acts directly on the chondrocytes to slow the pace of
hypertrophic chondrocyte differentiation during endo-
chondral ossification [63]. Increased MMP-13 expres-
sion and activity have been implicated in extensive
reorganization of ECM during endochondral ossification
[62]. Our results showed that outer meniscus cells had a
greater potency to suppress hypertrophic differentiation
of MSCs than inner meniscus cells. This finding was
particularly surprising since inner meniscus cells have
been shown to display a reduced osteogenic plasticity
relative to outer meniscus cells [41]. The reason for this
difference is unclear, but it is plausible that outer menis-
cus cells have a greater capacity to secrete PTHrP than
inner meniscus cells. PTHrP was shown to suppress the
mRNA expression of COL10A1 [64]. This aspect of the
study merits further investigation.
Co-culture of outer or inner meniscus cells with
MSCs exhibit similar capacity to synthesis cartilaginous
matrix with increased collagen II and proteoglycan
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content relative to mono-cultures of MSCs, outer or
inner meniscus cells. This finding suggests that primary
meniscus cells from the outer and reparative region of
the meniscus, after supplementation with MSCs, can in
principle be used to generate functional grafts or substi-
tutes for the reconstruction of irreparable or degenerate
inner meniscus. This possibility is supported by the
findings of Kobayashi and colleagues [65], who showed
that explants of the outer meniscus integrated well after
transplantation to the inner-avascular region of the
meniscus. Additionally, our finding regarding the
enhanced potency of outer meniscus cells (compared
with inner meniscus cells) to suppress hypertrophic dif-
ferentiation of MSCs makes it an attractive cell source
for the reconstruction of the inner meniscus. Further-
more, supplementation of primary meniscus cells with
MSCs will mitigate the need to expand meniscus cells
for cell-based meniscus tissue engineering purposes
since expanded meniscus cells lose their functional
matrix-forming phenotype during in vitro expansion.
Conclusions
Taken together, our results demonstrate that outer or
inner meniscus cells interact similarly and synergistically
with MSCs to increase matrix formation in the presence
of chondrogenic factors. However, outer meniscus cells
showed a more potent capacity to suppress the expres-
sion of hypertrophic differentiation of MSCs than cells
from the inner region of the meniscus. These results
suggest that the combination of outer meniscus cells
and MSCs can be used in cell-based tissue engineering
strategies to reconstruct the inner meniscus.
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